Which stock wins in a battle between these two retail pharmacy giants?
News & Analysis: Rite Aid
After mixed second-quarter results and remaining challenges, investors need more long-term assurance.
An analyst's negative take is causing a sell-off for the retail pharmacy stock.
Shares drop on a slow news day. What can explain the move?
Despite the company's weaker-than-expected first quarter, its new partnership with Amazon has investors feeling optimistic.
Shares of the pharmacy chain jumped on renewed hopes for an acquisition.
The market was none too pleased about the pharmacy retail chain's progress last quarter.
The negative impact of the pharmacy retailer's disappointing Q4 update last week continued to weigh on the stock.
The long-struggling pharmacy chain's earnings show the company still has a tough road ahead of it.
Investors approved a move that should keep it on the New York Stock Exchange, but shares have now lost more than 90% of their value over the last three years.
Shares drop by double-digits after the company announced the termination of a merger agreement. Here's what investors need to know.